Sigilon Therapeutics (SGTX) News Today → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free SGTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMCRB Seres Therapeutics, Inc.seekingalpha.com - April 14 at 10:19 PMBeam Therapeutics Inc.wsj.com - October 22 at 3:55 AMWhy These 3 Large Caps Are Bucking the August Slump (SGTX)marketbeat.com - August 22 at 7:49 AMEli Lilly Concludes Acquisition Of Sigilon Therapeuticsmarkets.businessinsider.com - August 14 at 2:43 PMLilly Completes Acquisition of Sigilon Therapeuticsfinance.yahoo.com - August 14 at 2:43 PMmarketbeat.com - August 11 at 6:02 AMSGTX - Sigilon Therapeutics, Inc.finance.yahoo.com - August 1 at 6:40 PMInside Eli Lilly's Strategic Investment In Sigilon: An Opportunity Overlookedmsn.com - July 31 at 7:24 PMSIGILON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigilon ...businesswire.com - July 21 at 7:56 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WMC, SGTX, AJX, IMNMmarkets.businessinsider.com - July 18 at 2:17 PMCanaccord Genuity Maintains Sigilon Therapeutics (SGTX) Buy Recommendationmsn.com - July 6 at 9:30 AMSigilon Therapeutics (SGTX) Price Target Decreased by 6.27% to 48.28msn.com - July 6 at 9:30 AM5 big deal reports: Overstock snags Bed Bath & Beyond IP; Visa pays $1B for Pismomsn.com - July 3 at 8:43 AMSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Sigilon Therapeutics, Inc. Buyoutbenzinga.com - June 29 at 11:45 PMModerna Billionaire Set to Score 3,000% Gain on Tiny Biotechfinance.yahoo.com - June 29 at 6:45 PMEli Lilly and Company: Lilly to Acquire Sigilon Therapeuticsfinanznachrichten.de - June 29 at 1:44 PMHealth Care Company Eli Lilly Announces Acquisition of Sigilon Therapeuticsmsn.com - June 29 at 1:44 PMSigilon stock up 500% on Lilly acquisition newsbizjournals.com - June 29 at 1:44 PMSigilon Therapeutics Shares Are Shooting Higher Today - What's Going Onfinance.yahoo.com - June 29 at 1:44 PMmarketbeat.com - June 29 at 9:35 AMSigilon stock skyrockets 650% on buyout deal with Eli Lillymsn.com - June 29 at 8:43 AMEli Lilly To Acquire Sigilon Therapeuticsmarkets.businessinsider.com - June 29 at 8:43 AMWhy Is Sigilon Therapeutics (SGTX) Stock Up 691% Today?msn.com - June 29 at 8:43 AMSGTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Sigilon Therapeutics, Inc. Is Fair to Shareholderstechnews.tmcnet.com - June 29 at 8:43 AMLilly to Acquire Sigilon Therapeuticsfinance.yahoo.com - June 29 at 8:43 AMEli Lilly to buy Sigilon Therapeutics to expand diabetes treatmentsfinance.yahoo.com - June 29 at 8:43 AMMorgan Stanley Sticks to Their Hold Rating for Sigilon Therapeutics (SGTX)markets.businessinsider.com - May 26 at 10:57 AMMorgan Stanley Maintains Sigilon Therapeutics (SGTX) Equal-Weight Recommendationmsn.com - May 25 at 8:16 PMSigilon Therapeutics's Return On Capital Employed Overviewmsn.com - May 24 at 2:33 PMmarketbeat.com - May 23 at 11:36 AMSigilon Therapeutics, Inc.: Sigilon Announces Reverse Stock Split of Common Stockfinanznachrichten.de - May 22 at 12:33 PMSigilon Therapeutics Announces One-for-13 Reverse Stock Split - Quick Factsmarkets.businessinsider.com - May 22 at 12:33 PMSigilon Therapeutics to effect 13-for-1 reverse stock splitmsn.com - May 22 at 12:33 PMSigilon Announces Reverse Stock Split of Common Stockfinance.yahoo.com - May 22 at 12:33 PMSigilon Therapeutics, Inc.: Sigilon Therapeutics Reports First Quarter 2023 Financial Results and Business Highlightsfinanznachrichten.de - May 9 at 10:48 AMSigilon Therapeutics GAAP EPS of -$0.23 in-line, revenue of $4.86M beats by $1.76Mmsn.com - May 9 at 10:48 AMSigilon Therapeutics to Present at the Needham Virtual Healthcare Conferencefinance.yahoo.com - April 18 at 10:14 AMRevenues Working Against Sigilon Therapeutics, Inc.'s (NASDAQ:SGTX) Share Price Following 34% Divefinance.yahoo.com - April 17 at 10:03 AMSigilon Therapeutics, Inc.: Sigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlightsfinanznachrichten.de - March 15 at 5:29 PMSigilon Therapeutics GAAP EPS of -$0.21 beats by $0.17, revenue of $2.64M misses by $0.03Mmsn.com - March 14 at 9:27 PMSigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlightsfinance.yahoo.com - March 14 at 4:26 PMmarketbeat.com - March 14 at 10:44 AMShort Volatility Alert: Sigilon Therapeuticsbenzinga.com - February 28 at 10:33 AMWhy Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarketmsn.com - January 19 at 10:26 AMSigilon Therapeutics Third Quarter 2022 Earnings: Beats Expectationsfinance.yahoo.com - November 12 at 1:06 PMSigilon Therapeutics, Inc.: Sigilon Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlightsfinanznachrichten.de - November 10 at 7:39 PMSigilon Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlightsfinance.yahoo.com - November 10 at 7:39 PMSigilon Therapeutics, Inc. (SGTX) Reports Q3 Loss, Tops Revenue Estimatesfinance.yahoo.com - November 10 at 7:39 PMDelix Therapeutics Expands World-Class Team with First Head of R&Dfinance.yahoo.com - September 24 at 4:09 PMAspect Biosystems Appoints Three New Board Membersbenzinga.com - September 23 at 8:12 AM Get Sigilon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Secret Bull Market Starts in This Unusual Sector (Ad)"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. SGTX Media Mentions By Week SGTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGTX News Sentiment▼0.000.52▲Average Medical News Sentiment SGTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGTX Articles This Week▼10▲SGTX Articles Average Week Get Sigilon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RPHM News Today GANX News Today FIXX News Today VHAQ News Today NXTC News Today KZR News Today HCWB News Today AADI News Today SCYX News Today BLRX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGTX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceOptions trading has suddenly become more reliable.Eagle PublishingHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sigilon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.